| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/13/2011 | US20110250587 Novel method for generation of rna virus |
| 10/13/2011 | US20110250586 System and method for concentrating samples |
| 10/13/2011 | US20110250585 Organ mimic device with microchannels and methods of use and manufacturing thereof |
| 10/13/2011 | US20110250584 Method for Screening Cancer Therapeutic Agent Using Galectin-3, GSK-3Betta, and Fascin-1 |
| 10/13/2011 | US20110250583 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b; novel influenza a/h1n1; and a novel influenza a/h1n1 rna sequence mutation associated with oseltamivir resistance |
| 10/13/2011 | US20110250236 Stem cells derived from the carotid body and uses thereof |
| 10/13/2011 | US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 10/13/2011 | US20110250204 Methods and compositions for diagnosing and treating diseases |
| 10/13/2011 | US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease |
| 10/13/2011 | US20110250192 Use of microrna signatures for assessing risk levels of neuroblastoma patients |
| 10/13/2011 | US20110250185 Tumor suppression using placental stem cells |
| 10/13/2011 | US20110250184 Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents in human |
| 10/13/2011 | US20110250179 Methods for treatment and diagnosis of cancer |
| 10/13/2011 | US20110250141 Methods For Improving Skin Quality |
| 10/13/2011 | US20110250137 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation |
| 10/13/2011 | US20110250129 Bioluminescence imaging-based screening assay and inhibitors of abcg2 |
| 10/13/2011 | US20110250128 Method for tissue characterization based on beta radiation and coincident Cherenkov radiation of a radiotracer |
| 10/13/2011 | CA2795880A1 Rad51c as a human cancer susceptibility gene |
| 10/13/2011 | CA2795776A1 Circulating biomarkers for disease |
| 10/13/2011 | CA2795695A1 Microrna-controlled recombinant vaccinia virus and use thereof |
| 10/13/2011 | CA2795042A1 Tools and method for nanopores unzipping-dependent nucleic acid sequencing |
| 10/13/2011 | CA2795008A1 Buffy coat separator float systems and methods |
| 10/13/2011 | CA2794709A1 Selection and use of host cells for production of glycoproteins |
| 10/13/2011 | CA2794697A1 High mannose glycans |
| 10/13/2011 | CA2794522A1 Spatially encoded biological assays |
| 10/13/2011 | CA2793940A1 Therapeutic use of the .beta.2m protein |
| 10/13/2011 | CA2791825A1 Assay for phytol-free chlorophyll derivatives |
| 10/12/2011 | EP2374902A1 Nucleic acid sequencing system and method |
| 10/12/2011 | EP2374901A1 Characterisation of gene function using double stranded RNA inhibition |
| 10/12/2011 | EP2374900A1 Polynucleotides for the amplification and analysis of whole genome and whole transcriptome libraries generated by a dna polymerization process |
| 10/12/2011 | EP2374899A1 Efficient surface plasmon resonance based protease assay |
| 10/12/2011 | EP2374898A1 Biosensor support |
| 10/12/2011 | EP2374896A1 Trend analysis and statistical process control using multitargeted screening assays |
| 10/12/2011 | EP2374891A2 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 10/12/2011 | EP2374890A2 Fen-1 endonucleases, mixtures and cleavage methods |
| 10/12/2011 | EP2374884A2 Human miRNAs isolated from mesenchymal stem cells |
| 10/12/2011 | EP2374883A1 Anti-cd4 antibody |
| 10/12/2011 | EP2374875A2 Mutant hydrolase proteins with enhanced kinetics and funcitional expression |
| 10/12/2011 | EP2374874A2 Detergent free polymerases |
| 10/12/2011 | EP2374542A1 Small size gene analysis apparatus |
| 10/12/2011 | EP2374470A1 Therapeutic use of the Beta2m protein |
| 10/12/2011 | EP2374003A1 Methods for the treatment, the prognostic assessment and the detection of breast cancer |
| 10/12/2011 | EP2373995A2 Polymers for use in centrifugalseparation of liquids |
| 10/12/2011 | EP2373819A1 Multiparameter assay |
| 10/12/2011 | EP2373818A1 Method for amplifying and/or detecting nucleic acids, kits and uses of said method |
| 10/12/2011 | EP2373817A2 Methods and compositions for hybridizing nucleic acids |
| 10/12/2011 | EP2373816A2 Methods for screening, predicting and monitoring prostate cancer |
| 10/12/2011 | EP2373815A1 Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer |
| 10/12/2011 | EP2373814A2 Genotyping dihydropyrimidine dehydrogenase deficiency |
| 10/12/2011 | EP2373813A1 Method for detecting methicillin-resistant staphylococcus aureus (mrsa) strains |
| 10/12/2011 | EP2373812A1 Particle-assisted nucleic acid sequencing |
| 10/12/2011 | EP2373811A1 Use of cyclodextrins to improve the specificity, sensitivity and yield of nucleic acid amplification reactions |
| 10/12/2011 | EP2373810A1 Methods and compositions for cancer prognosis |
| 10/12/2011 | EP2373809A1 Methods for identifying erbb2 alteration in tumors |
| 10/12/2011 | EP2373808A1 Enhanced taqman probe based amplification |
| 10/12/2011 | EP2373807A1 Pcr-based method of synthesizing a nucleic acid molecule |
| 10/12/2011 | EP2373806A1 Screening assays for the identification of bace2 inhibitors |
| 10/12/2011 | EP2373805A1 Low total salt reagent compositions and systems for biosensors |
| 10/12/2011 | EP2373804A1 Compositions for improving gene amplification |
| 10/12/2011 | EP2373795A2 Universal biological sample processing |
| 10/12/2011 | EP2373794A1 Nectin-4 for target genes of cancer therapy and diagnosis |
| 10/12/2011 | EP2373340A2 Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr |
| 10/12/2011 | EP2373301A2 Methods of diagnosing and treating motor neuron diseases |
| 10/12/2011 | EP2245181B1 Selectivity profiling of pi3k interacting molecules against multiple targets |
| 10/12/2011 | EP2176433B1 Desaturases and methods for producing polyunsaturated fatty acids in transgenic organisms |
| 10/12/2011 | EP2058392B1 Dna fragment used in the form attached to 5'-terminus of primer for use in amplification reaction of nucleic acid, and use thereof |
| 10/12/2011 | EP2029745B1 Diagnostic methods and markers |
| 10/12/2011 | EP2017333B1 Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell |
| 10/12/2011 | EP2002021B1 Methods for assaying protein-protein interaction |
| 10/12/2011 | EP1988174B1 Method for determination of condition of disseminated intravascular coagulation syndrome |
| 10/12/2011 | EP1836312B1 Methods and compositions for diagnosing age-related macular degenration |
| 10/12/2011 | EP1692272B1 Inhibition assay method and device for detection of antibiotics |
| 10/12/2011 | EP1652923B1 Gene overexpressed in cancer |
| 10/12/2011 | EP1448995B9 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 10/12/2011 | EP1191096B1 Ovel protein and dna thereof |
| 10/12/2011 | CN202007230U Kit for series of gynecological examinations on bacterial vaginosis |
| 10/12/2011 | CN1845989B Recombinant production of antimicrobial agents |
| 10/12/2011 | CN102216775A Susceptibility to hsp90-inhibitors |
| 10/12/2011 | CN102216771A Gene sequences for the detection of chikungunya and dengue fever |
| 10/12/2011 | CN102216762A Nanostructured microelectrodes and biosensing devices incorporating the same |
| 10/12/2011 | CN102216757A Plasmonic electricity |
| 10/12/2011 | CN102216472A Rna detection method |
| 10/12/2011 | CN102216471A Method for the urinary detection of bladder cancer |
| 10/12/2011 | CN102216470A Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients |
| 10/12/2011 | CN102216469A High-throughput assay for evaluating dipeptidyl peptidase i activity |
| 10/12/2011 | CN102216468A Methods for determining the risk of prenatal complications |
| 10/12/2011 | CN102216467A Compositions and methods for the rapid growth and detection of microorganisms |
| 10/12/2011 | CN102216456A Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| 10/12/2011 | CN102215966A Microfluidic multiplexed cellular and molecular analysis device and method |
| 10/12/2011 | CN102215873A Dendritic cell modulatory molecule |
| 10/12/2011 | CN102215872A Methods and compositions for the treatment of cancer |
| 10/12/2011 | CN102215870A Diagnosis method and therapeutic method for cancer |
| 10/12/2011 | CN102212623A Two-color fluorescence quantitative polymerase chain reaction (PCR) combined detection method of swine fever virus and blue ear disease virus and kit thereof |
| 10/12/2011 | CN102212622A Reverse transcription-polymerase chain reaction (RT-PCR) detection method and kit for quickly diagnosing bovine parainfluenza virus 3 (BPIV-3) |
| 10/12/2011 | CN102212621A Detection kit and detection method for hepatitis B virus genotyping |
| 10/12/2011 | CN102212620A Measurement and audit kit for detecting three fish rhabdoviruses |
| 10/12/2011 | CN102212619A Hepatitis B virus pre-C/C-region mutations and applications thereof |
| 10/12/2011 | CN102212618A Fourfold fluorescence quantitative PCR (Polymerase Chain Reaction) kit and application |
| 10/12/2011 | CN102212617A Primer pair, probe and kit for detecting classical swine fever virus wild strain |
| 10/12/2011 | CN102212616A Preparation method for synthesizing nanocomposite from graphene oxide and organic dye |